| 20/10/2025 | China Resources Pharmaceutical Group Limited | 1206(L) | -29,627,394(L) | | 148,136,971(L) | 28.79 | | 20/10/2025 | 華潤三九醫藥股份有限公司China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1206(L) | -19,335,714(L) | | 96,678,571(L) | 18.79 | | 20/10/2025 | Tasly Pharmaceutical Group Co.,Ltd.* (天士力医药集团股份有限公司) | 1206(L) | -19,335,714(L) | | 96,678,571(L) | 18.79 | | 20/10/2025 | Tasly (Hong Kong) Pharmaceutical Investment Limited | 1206(L) | -19,335,714(L) | | 96,678,571(L) | 18.79 | | 20/10/2025 | Tianjin Zhongzhi Technology Development Co., Ltd.* (天津众智科技发展有限公司) | 1206(L) | -19,335,714(L) | | 96,678,571(L) | 18.79 | | 20/10/2025 | China Resources Company Limited | 1206(L) | -29,627,394(L) | | 148,136,971(L) | 28.79 | | 18/09/2025 | 霍志達 | 1013(L) | +123,135,430(L) | | 123,135,430(L) | 19.31 | | 18/09/2025 | 張兆佳 | 1013(L) | +123,135,430(L) | | 123,135,430(L) | 19.31 | | 18/09/2025 | Maxa Financial Group Holdings Limited | 1013(L) | +123,135,430(L) | | 123,135,430(L) | 19.31 | | 18/09/2025 | Maxa Asset Management Limited | 1013(L) | +123,135,430(L) | | 123,135,430(L) | 19.31 | | 18/09/2025 | Maxa Financial Group Limited | 1013(L) | +123,135,430(L) | | 123,135,430(L) | 19.31 | | 10/09/2025 | 鄭鉉哲 | 1213(L) | -50,000(L) | | 30,823,000(L) | 5.99 | | 10/09/2025 | Evodevo Ltd | 1213(L) | -50,000(L) | | 30,823,000(L) | 5.99 | | 28/08/2025 | Evodevo Ltd | 1213(L) | -3,291,000(L) | | 35,806,000(L) | 6.96 | | 28/08/2025 | 鄭鉉哲 | 1213(L) | -3,291,000(L) | | 35,806,000(L) | 6.96 | | 15/07/2025 | Tasly (Hong Kong) Pharmaceutical Investment Limited | 1213(L) | -94,493,150(L) | | 96,678,571(L) | 18.79 | | 15/07/2025 | 曹龍祥 | 1316(L) | 68,493,150(L) | | 68,493,150(L) | 13.31 | | 15/07/2025 | Tasly Pharmaceutical Group Co.,Ltd.* (天士力医药集团股份有限公司) | 1213(L) | -94,493,150(L) | | 96,678,571(L) | 18.79 | | 15/07/2025 | Tianjin Zhongzhi Technology Development Co., Ltd.* (天津众智科技发展有限公司) | 1213(L) | -94,493,150(L) | | 96,678,571(L) | 18.79 | | 15/07/2025 | 江蘇濟川控股集團有限公司 | 1316(L) | 68,493,150(L) | | 68,493,150(L) | 13.31 | | 15/07/2025 | 西藏嘉澤創業投資有限公司 | 1316(L) | 68,493,150(L) | | 68,493,150(L) | 13.31 | | 15/07/2025 | 曹飛 | 1316(L) | 68,493,150(L) | | 68,493,150(L) | 13.31 | | 15/07/2025 | China Resources Pharmaceutical Group Limited | 1213(L) | -94,493,150(L) | | 148,136,971(L) | 28.79 | | 15/07/2025 | 華潤三九醫藥股份有限公司China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1213(L) | -94,493,150(L) | | 96,678,571(L) | 18.79 | | 15/07/2025 | Jiaze Global Capital Limited | 10031(L) | 68,493,150(L) | | 68,493,150(L) | 13.31 | | 15/07/2025 | 嘉泽宏业(天津)科技有限公司 | 10031(L) | 68,493,150(L) | | 68,493,150(L) | 13.31 | | 15/07/2025 | China Resources Company Limited | 1213(L) | -94,493,150(L) | | 148,136,971(L) | 28.79 | | 27/03/2025 | 闫希军 | 1213(L) | | | 0(L) | 0.00 | | 27/03/2025 | 吴迺峰 | 1213(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tianjin Tongming Technology Development Partnership (Limited Partnership)*(天津通明科技发展合伙企业(有限合伙)) | 1711(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tianjin Kangshun Technology Development Partnership (Limited Partnership)*(天津康顺科技发展合伙企业(有限合伙)) | 1711(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tianjin Heyue Technology Development Partnership (Limited Partnership)*(天津和悦科技发展合伙企业(有限合伙)) | 1711(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tasly Holding Group Co., Ltd.* (天士力控股集团有限公司) | 1711(L) | | | 0(L) | 0.00 | | 27/03/2025 | 闫凯境 | 1213(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tianjin Tasly Health Industry Investment Group Co., Ltd.*(天津天士力大健康产业投资集团有限公司) | 1711(L) | | | 0(L) | 0.00 | | 27/03/2025 | 李畇慧 | 1213(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tianjin Shunqi Technology Development Partnership (Limited Partnership)*(天津顺祺科技发展合伙企业(有限合伙)) | 1711(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tianjin Hongxun Technology Development Partnership (Limited Partnership)*(天津鸿勋科技发展合伙企业(有限合伙)) | 1711(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tianjin Fuhuade Technology Development Co., Ltd.*(天津富华德科技开发有限公司) | 1711(L) | | | 0(L) | 0.00 | | 27/03/2025 | Tianjin Shanzhen Technology Development Partnership (Limited Partnership)*(天津善臻科技发展合伙企业(有限合伙)) | 1711(L) | | | 0(L) | 0.00 | | | 1 2 |
|